A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

被引:115
作者
Liebowitz, LD
Ashbee, HR
Evans, EGV
Chong, Y
Mallatova, N
Zaidi, M
Gibbs, D
机构
[1] Giles Sci Inc, Santa Barbara, CA 93140 USA
[2] Univ Witwatersrand, Dept Med Microbiol, ZA-2000 Johannesburg, South Africa
[3] S African Inst Med Res, ZA-2000 Johannesburg, South Africa
[4] Univ Leeds, Div Microbiol, Mycol Reference Ctr, Leeds LS2 9JT, W Yorkshire, England
[5] Yonsei Univ, Coll Med, Severance Hosp, Dept Clin Pathol, Seoul, South Korea
[6] Hosp Ceske Budejovice, Dept Med Microbiol, Ceske Budejovice 37087, Czech Republic
[7] Hosp Gen OHoran, Dept Invest, Merida 97000, Mexico
关键词
D O I
10.1016/S0732-8893(01)00243-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in-vitro activity of fluconazole against 46,831 yeast isolates collected over a two-year period from 57 laboratories in 33 countries worldwide was assessed using a disc diffusion method. Candida albicans was the organism isolated most frequently, accounting for 68.6% of the total number of isolates. C, glabrata, C, tropicalis, C parapsilosis and C. krusei and Cryptococcus neoformans represented 9.9, 4.7, 4.3, 1.9, and 1.4% of isolates respectively during the 2 year period and rates varied markedly between countries. In 1999 data blood isolates represented 4.9% of all isolates and intensive care unit isolates represented 9.9%, In both the 1998 and 1999 data, 99% of C, albicans were fully susceptible (S) to fluconazole, and 95.6% of all species of yeasts tested were S or susceptible-dose dependent (S-DD) to fluconazole. No emerging trends of resistance were noted with any of the Candida spp. tested as 96% of all isolates retained susceptibility (S or S-DD) to this agent. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 26 条
[1]   Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature [J].
Anaissie, EJ ;
Darouiche, RO ;
AbiSaid, D ;
Uzun, O ;
Mera, J ;
Gentry, LO ;
Williams, T ;
Kontoyiannis, DP ;
Karl, CL ;
Bodey, GP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :964-972
[2]   SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989 [J].
BANERJEE, SN ;
EMORI, TG ;
CULVER, DH ;
GAYNES, RP ;
JARVIS, WR ;
HORAN, T ;
EDWARDS, JR ;
TOLSON, J ;
HENDERSON, T ;
MARTONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S89
[3]   Fluconazole disk diffusion procedure for determining susceptibility of Candida species [J].
Barry, AL ;
Brown, SD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) :2154-2157
[4]   Evaluation of the susceptibility of pathogenic Candida species to fluconazole [J].
Bille, J ;
Glauser, MP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (12) :924-928
[5]  
BILLE J, 1998, BIOMIC VIDEO READING
[6]   FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS [J].
BOKEN, DJ ;
SWINDELLS, S ;
RINALDI, MG .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) :1018-1021
[7]   Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center [J].
Boschman, CR ;
Bodnar, UR ;
Tornatore, MA ;
Obias, AA ;
Noskin, GA ;
Englund, K ;
Postelnick, MA ;
Suriano, T ;
Peterson, LR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :734-738
[8]   FLUCONAZOLE FAILURE IN THE TREATMENT OF INVASIVE MYCOSES [J].
EVANS, TG ;
MAYER, J ;
COHEN, S ;
CLASSEN, D ;
CARROLL, K .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1232-1235
[9]   NOSOCOMIAL FUNGEMIA IN A LARGE COMMUNITY TEACHING HOSPITAL [J].
HARVEY, RL ;
MYERS, JP .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (12) :2117-2120
[10]  
Horsburgh C R Jr, 1983, Am J Med, V74, P23, DOI 10.1016/0002-9343(83)90511-9